Summary
Positron emission tomography with F-18 deoxyglucose was used to assess cortical metabolic rate during an olfactory memory task in six patients with senile dementia of the Alzheimer’s type and six healthy, age-matched controls. Decreases in metabolic rate were observed in the anterior portion of the medial temporal cortex, especially on the left in the patients. This region is known to receive a large olfactory input, and to have been implicated in the encoding of human memory. Our results are consistent with earlier reports of temporal lobe decreases in metabolic rate, extending them by examining areas salient to the behavioral loss.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
American Psychiatric Association (1980) DSM-III: diagnostic and statistical manual, 3rd edn. Washington DC, APA
Blessed G, Tomlinson BD, et al (1968) The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br J Psychiatry 114: 797–811
Buchsbaum MS, De Lisi LE, et al (1984) Anteroposterior gradients in cerebral glucose use in schizophrenia and affective disorders. Arch Gen Psychiatry 41: 1159–1166
Buchsbaum MS, Wu J, et al (1987) Positron emission tomography assessment of effects of benzodiazepines on regional glucose metabolic rate in patients with anxiety disorders. Life Sci 40: 2393–2400
De Leon MJ, Ferris SH, et al (1983) Positron emission tomographic studies of aging and Alzheimer’s disease. Am J Neuroradiol 4: 568–571
Dixon WJ (1981) BMDP statistical software. University of California Press, Berkeley, pp 388–412
Duara R, Grady C, et al (1986) Positron emission tomography in Alzheimer’s disease. Neurology 36: 879–887
Folstein M, Folstein S, et al (1975) The mini-mental state examination. J Psychiatr Res 12: 189–198
Friedland RP, Budinger TF, et al (1983) Regional cerebral metabolic alterations in dementia of the Alzheimer type: positron emission tomography with [18F]fluorodeoxyglucose. J Comput Assist Tomogr 7: 590–598
Friedland RP, Budinger TF, et al (1985) Alzheimer’s disease: anterior-posterior and lateral hemispheric alterations in cortical glucose utilization. Neurosci Lett 53: 235–240
Hachinski VC, Iliff LD, et al (1975) Cerebral blood flow in dementia. Arch Neurol 32: 632–637
Harbaugh RE, Roberts DW, et al (1984) Preliminary report: intracranial cholinergic drug infusion in patients with Alzheimer’s disease. Neurosurgery 15: 514–518
Hyman BI, van Hoesen GW, et al (1984) Alzheimer’s disease: cell-specific pathology isolates the hippocampal formation. Science 225: 1168–1170
McGeer PL, Kamo H, et al (1986) Positron emission tomography in patients with clinically diagnosed Alzheimer’s disease. Can Med Assoc J 134: 597–607
McKhann G, Drachman D, et al (1984) Clinical diagnosis of Alzheimer’s disease. Neurology 34: 939–944
Miller JD, de Leon MJ, et al (1987) Abnormal temporal lobe response in Alzheimer’s disease during cognitive processing as measured by 11C-2-Deoxy-D-Glucose and PET. J Cereb Blood Flow Metab 7: 248–251
Pearson RCA, Esiri MM, et al (1985) Anatomical correlates of the distribution of the pathological changes in the neocortex in Alzheimer’s disease. Proc Natl Acad Sci USA 82: 4531–4534
Phelps ME, Huang SC, et al (1979) Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxyglucose: validation of method. Ann Neurol 6: 371–388
Roberts M, Hanaway J (1970) Atlas of the human brain in section. Lea and Febiger, Philadelphia
Salamon G, Huang YP (1980) Computed tomography of the brain. Springer, Berlin Heidelberg New York, p 132
Sokoloff L, Reivich M, et al (1977) The [14C]Deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J Neurochem 28: 897–916
Tamminga CA, Foster NL, et al (1987) Alzheimer’s disease: low cerebral somatostatin levels correlate with impaired cognitive function and cortical metabolism. Neurology 37: 161–165
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Springer-Verlag Wien
About this chapter
Cite this chapter
Buchsbaum, M.S. et al. (1990). Decreased hippocampal metabolic rate in patients with SDAT assessed by positron emission tomography during olfactory memory task. In: Maurer, K., Riederer, P., Beckmann, H. (eds) Alzheimer’s Disease. Epidemiology, Neuropathology, Neurochemistry, and Clinics. Key Topics in Brain Research. Springer, Vienna. https://doi.org/10.1007/978-3-7091-3396-5_53
Download citation
DOI: https://doi.org/10.1007/978-3-7091-3396-5_53
Publisher Name: Springer, Vienna
Print ISBN: 978-3-211-82197-8
Online ISBN: 978-3-7091-3396-5
eBook Packages: Springer Book Archive